These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18003831)

  • 21. Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE.
    Wang C; Gold BG; Kaler LJ; Yu X; Afentoulis ME; Burrows GG; Vandenbark AA; Bourdette DN; Offner H
    J Neurochem; 2006 Sep; 98(6):1817-27. PubMed ID: 16899071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RTL therapy for multiple sclerosis: a Phase I clinical study.
    Offner H; Sinha S; Burrows GG; Ferro AJ; Vandenbark AA
    J Neuroimmunol; 2011 Feb; 231(1-2):7-14. PubMed ID: 20965577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis.
    Chaudhary P; Marracci GH; Bourdette DN
    J Neuroimmunol; 2006 Jun; 175(1-2):87-96. PubMed ID: 16644024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin.
    Stosic-Grujicic S; Savic-Radojevic A; Maksimovic-Ivanic D; Markovic M; Bumbasirevic V; Ramic Z; Mostarica-Stojkovic M
    J Neuroimmunol; 2002 Sep; 130(1-2):66-77. PubMed ID: 12225889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble MOG35-55/I-A(b) dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic T cells.
    Gong Y; Wang Z; Liang Z; Duan H; Ouyang L; Yu Q; Xu Z; Shen G; Weng X; Wu X
    PLoS One; 2012; 7(10):e47435. PubMed ID: 23077616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
    Thomé R; Moraes AS; Bombeiro AL; Farias Ados S; Francelin C; da Costa TA; Di Gangi R; dos Santos LM; de Oliveira AL; Verinaud L
    PLoS One; 2013; 8(6):e65913. PubMed ID: 23799062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis.
    Liu Y; Bando Y; Vargas-Lowy D; Elyaman W; Khoury SJ; Huang T; Reif K; Chitnis T
    J Neurosci; 2010 Feb; 30(6):2025-38. PubMed ID: 20147531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inconsistence between number and function of autoreactive T cells in the course of experimental autoimmune encephalomyelitis.
    Wan X; Pei W; Zhang Y; Zhang L; Shahzad KA; Xu T; Shen C
    Immunol Invest; 2018 Jan; 47(1):1-17. PubMed ID: 28872930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
    Popovic M; Stanojevic Z; Tosic J; Isakovic A; Paunovic V; Petricevic S; Martinovic T; Ciric D; Kravic-Stevovic T; Soskic V; Kostic-Rajacic S; Shakib K; Bumbasirevic V; Trajkovic V
    J Neurochem; 2015 Oct; 135(1):125-38. PubMed ID: 26083644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.
    Zappia E; Casazza S; Pedemonte E; Benvenuto F; Bonanni I; Gerdoni E; Giunti D; Ceravolo A; Cazzanti F; Frassoni F; Mancardi G; Uccelli A
    Blood; 2005 Sep; 106(5):1755-61. PubMed ID: 15905186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis model.
    Jung EJ; Hur M; Kim YL; Lee GH; Kim J; Kim I; Lee M; Han HK; Kim MS; Hwang S; Kim S; Woo AM; Yoon Y; Park HJ; Won J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1005-13. PubMed ID: 19741152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10-60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model.
    Kap YS; van Driel N; Arends R; Rouwendal G; Verolin M; Blezer E; Lycke N; 't Hart BA
    Clin Exp Immunol; 2015 Apr; 180(1):28-39. PubMed ID: 25393803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental autoimmune encephalomyelitis development is aggravated by Candida albicans infection.
    Fraga-Silva TF; Mimura LA; Marchetti CM; Chiuso-Minicucci F; França TG; Zorzella-Pezavento SF; Venturini J; Arruda MS; Sartori A
    J Immunol Res; 2015; 2015():635052. PubMed ID: 25969836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
    Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L
    Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice.
    Mendel Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1996 Oct; 26(10):2470-9. PubMed ID: 8898962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis.
    Koo JH; Kim DH; Cha D; Kang MJ; Choi JM
    Theranostics; 2020; 10(7):3138-3150. PubMed ID: 32194859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.